FDA inspection
GlaxoSmithKline LLC: FDA inspection ending Nov 13, 2003
FDA inspection 301190 · No Action Indicated (NAI) · King of Prussia, PA
Key facts
| Inspection ID | 301190 |
|---|---|
| Firm | GlaxoSmithKline LLC |
| FEI number | 1000522100 |
| Address | 709 Swedeland Rd |
| City | King of Prussia |
| State | PA |
| ZIP | 19406-2711 |
| Fiscal year | 2004 |
| Inspection end date | Nov 13, 2003 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data